Literature DB >> 18487053

Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB.

Soo Sung Kang1, Muriel Cuendet, Denise C Endringer, Vicki L Croy, John M Pezzuto, Mark A Lipton.   

Abstract

Resveratrol (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2) and the transcription factor NF-kappaB. A 78-membered library of resveratrol analogues in which the substituents on the two aryl rings and alkene were varied was synthesized using a solid-phase Wittig olefination reaction. The library contains inhibitors against all three proteins that were more potent than resveratrol itself. Preliminary structure-activity relationships were also obtained from these data that permitted the derivation of pharmacophore models for each of the three targets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18487053     DOI: 10.1016/j.bmc.2008.04.031

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  18 in total

Review 1.  Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009.

Authors:  Roland E Dolle; Bertrand Le Bourdonnec; Karin Worm; Guillermo A Morales; Craig J Thomas; Wei Zhang
Journal:  J Comb Chem       Date:  2010-10-05

2.  Anti-inflammatory effects of Clematis chinensis Osbeck extract(AR-6) may be associated with NF-κB, TNF-α, and COX-2 in collagen-induced arthritis in rat.

Authors:  Cheng Peng; Pathirage Kamal Perera; Yun-Man Li; Wei-Rong Fang; Li-Fang Liu; Feng-Wen Li
Journal:  Rheumatol Int       Date:  2011-09-20       Impact factor: 2.631

Review 3.  Resveratrol and resveratrol analogues--structure-activity relationship.

Authors:  Thomas Szekeres; Monika Fritzer-Szekeres; Philipp Saiko; Walter Jäger
Journal:  Pharm Res       Date:  2010-03-16       Impact factor: 4.200

4.  Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

Authors:  Juma Hoshino; Eun-Jung Park; Tamara P Kondratyuk; Laura Marler; John M Pezzuto; Richard B van Breemen; Shunyan Mo; Yongchao Li; Mark Cushman
Journal:  J Med Chem       Date:  2010-07-08       Impact factor: 7.446

5.  Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.

Authors:  Sarah E St John; Katherine C Jensen; Soosung Kang; Yafang Chen; Barbara Calamini; Andrew D Mesecar; Mark A Lipton
Journal:  Bioorg Med Chem       Date:  2013-07-27       Impact factor: 3.641

6.  Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity.

Authors:  Tamara P Kondratyuk; Eun-Jung Park; Laura E Marler; Soyoun Ahn; Yang Yuan; Yongsoo Choi; Rui Yu; Richard B van Breemen; Bin Sun; Juma Hoshino; Mark Cushman; Katherine C Jermihov; Andrew D Mesecar; Clinton J Grubbs; John M Pezzuto
Journal:  Mol Nutr Food Res       Date:  2011-06-29       Impact factor: 5.914

Review 7.  Insulin resistance in Alzheimer's disease.

Authors:  Kelly T Dineley; Jordan B Jahrling; Larry Denner
Journal:  Neurobiol Dis       Date:  2014-09-16       Impact factor: 5.996

8.  Measurement of cyclooxygenase inhibition using liquid chromatography-tandem mass spectrometry.

Authors:  Hongmei Cao; Rui Yu; Yi Tao; Dejan Nikolic; Richard B van Breemen
Journal:  J Pharm Biomed Anal       Date:  2010-08-13       Impact factor: 3.935

9.  Discovery of cyclooxygenase inhibitors from medicinal plants used to treat inflammation.

Authors:  Hongmei Cao; Rui Yu; Yongsoo Choi; Zhong-Ze Ma; Hongjie Zhang; Wei Xiang; David Yue-Wei Lee; Brian M Berman; Kamal D Moudgil; Harry H S Fong; Richard B van Breemen
Journal:  Pharmacol Res       Date:  2010-02-24       Impact factor: 7.658

Review 10.  Resveratrol in cardiovascular disease: what is known from current research?

Authors:  Hong Wang; Yue-Jin Yang; Hai-Yan Qian; Qian Zhang; Hui Xu; Jian-Jun Li
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.